These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8723472)

  • 1. Zidovudine, trimethoprim, and dapsone pharmacokinetic interactions in patients with human immunodeficiency virus infection.
    Lee BL; Safrin S; Makrides V; Gambertoglio JG
    Antimicrob Agents Chemother; 1996 May; 40(5):1231-6. PubMed ID: 8723472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
    Medina I; Mills J; Leoung G; Hopewell PC; Lee B; Modin G; Benowitz N; Wofsy CB
    N Engl J Med; 1990 Sep; 323(12):776-82. PubMed ID: 2392131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary dapsone chemoprophylaxis for Pneumocystis carinii pneumonia in immunocompromised patients infected with the human immunodeficiency virus.
    Lucas CR; Sandland AM; Mijch A; Simpson JM
    Med J Aust; 1989 Jul; 151(1):30-3. PubMed ID: 2528052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
    Leoung GS; Mills J; Hopewell PC; Hughes W; Wofsy C
    Ann Intern Med; 1986 Jul; 105(1):45-8. PubMed ID: 2940954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
    Bozzette SA; Finkelstein DM; Spector SA; Frame P; Powderly WG; He W; Phillips L; Craven D; van der Horst C; Feinberg J
    N Engl J Med; 1995 Mar; 332(11):693-9. PubMed ID: 7854375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and prophylaxis of Pneumocystis carinii pneumonia.
    Fischl MA
    AIDS; 1988; 2 Suppl 1():S143-50. PubMed ID: 2976274
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.
    Martin MA; Cox PH; Beck K; Styer CM; Beall GN
    Arch Intern Med; 1992 Mar; 152(3):523-8. PubMed ID: 1546914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethoprim, alone or in combination with sulphamethoxazole, decreases the renal excretion of zidovudine and its glucuronide.
    Chatton JY; Munafo A; Chave JP; Steinhäuslin F; Roch-Ramel F; Glauser MP; Biollaz J
    Br J Clin Pharmacol; 1992 Dec; 34(6):551-4. PubMed ID: 1493087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions.
    Lee BL; Medina I; Benowitz NL; Jacob P; Wofsy CB; Mills J
    Ann Intern Med; 1989 Apr; 110(8):606-11. PubMed ID: 2784648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus infection in children.
    Hoernle EH; Reid TE
    Am J Health Syst Pharm; 1995 May; 52(9):961-79. PubMed ID: 7641035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia.
    Vöhringer HF; Arastéh K
    Clin Pharmacokinet; 1993 May; 24(5):388-412. PubMed ID: 8504623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.
    Falloon J; Lavelle J; Ogata-Arakaki D; Byrne A; Graziani A; Morgan A; Amantea MA; Ownby K; Polis M; Davey RT
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1580-7. PubMed ID: 7979291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
    Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E
    N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. Study Group.
    Salmon-Ceron D; Fontbonne A; Saba J; May T; Raffi F; Chidiac C; Patey O; Aboulker JP; Schwartz D; Vildé JL
    J Infect Dis; 1995 Sep; 172(3):656-64. PubMed ID: 7658056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis.
    Freedberg KA; Tosteson AN; Cohen CJ; Cotton DJ
    J Acquir Immune Defic Syndr (1988); 1991; 4(5):521-31. PubMed ID: 1673157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine, and lamivudine administered alone and in combination in adults with human immunodeficiency virus infection.
    Wang LH; Chittick GE; McDowell JA
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1708-15. PubMed ID: 10390227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIDS-related Pneumocystis carinii pneumonia successfully treated with dapsone-trimethoprim.
    Green ST; Goldberg DJ; Leach J; Christie PR; Kennedy DH
    Br J Clin Pharmacol; 1988 Oct; 26(4):487-8. PubMed ID: 3263877
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Torres RA; Barr M; Thorn M; Gregory G; Kiely S; Chanin E; Carlo C; Martin M; Thornton J
    Am J Med; 1993 Dec; 95(6):573-83. PubMed ID: 8018144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled trial of dapsone versus pyrimethamine-sulfadoxine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in patients with AIDS.
    Payen MC; De Wit S; Sommereijns B; Clumeck N
    Biomed Pharmacother; 1997; 51(10):439-45. PubMed ID: 9863502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.